Ability of Monoclonal Anti‐D Antibodies to Promote the Binding of Red Cells to Lymphocytes, Granulocytes and Monocytes

Anthony H. Merry, N.C. Hughes‐Jones(MRC Cancer Unit), Ewa Brojer(Instytut Hematologii i Transfuzjologi), Andrew G. Hadley, B Zupańska, Belinda M. Kumpel(NHS Blood and Transplant)

Vox Sanguinis

January 1, 1989

10.1111/j.1423-0410.1989.tb03048.x

Cited by 17

Related Papers

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

|Blood|2013|226

International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009

|Vox Sanguinis|2011|191

Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.

|PubMed|1994|107

Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?

|Trends in Immunology|2001|103

Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers

|Vox Sanguinis|2007|97